Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology

Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology

Background: Vitexicarpin (VIT), an isoflavone derived from various medicinal herbs, has shown promising anti-tumor activities against multiple cancer cells. However, the understanding of the mechanisms and potential targets of VIT in treating triple-negative breast cancer (TNBC) remains limited. Met...

Full description

Bibliographic Details
Main Authors: Tianhui Wu, Min Xiang, Yujiao Li, Yahan Gao, Da Teng, Minxuan Sun, Weiqiang Guo, Yuanshuai Zhou
Format: Article
Language:English
Published: IMR Press 2023-12-01
Series:Frontiers in Bioscience-Landmark
Subjects:
vitexicarpin
triple-negative breast cancer
network pharmacology
hsp90aa1
crebbp
hif-1a
Online Access:https://www.imrpress.com/journal/FBL/28/12/10.31083/j.fbl2812341

Internet

https://www.imrpress.com/journal/FBL/28/12/10.31083/j.fbl2812341

Similar Items